2023 Third Quarter Financial and Corporate Update Third Quarter 2023 Earnings Call Agenda Ben Strain Introduction Head of Investor Relations Hervé Hoppenot Key Highlights Chief Executive Officer Barry Flannelly Commercial Highlights General Manager, North America Pablo Cagnoni R&D Update President, Head of Research & Development Steven Stein Clinical Update Chief Medical Officer Christiana Stamoulis Financial Review Chief Financial Officer 2 Forward-Looking Statements Except for the historical information s ...